Almirall to Accelerate Drug Discovery Process Utilizing Iktos’ AI Technology

 Almirall to Accelerate Drug Discovery Process Utilizing Iktos’ AI Technology

Almirall to Accelerate Drug Discovery Process Utilizing Iktos’ AI Technology

Shots:

  • Almirall will leverage Iktos’s generative modeling AI technology for compound optimization and accelerating the identification of drug candidates for its drug discovery program
  • The collaboration will provide an opportunity to Almirall to combine its expertise with Iktos’ AI precision and celerity to improve QoL
  • Iktos’ AI technology is based on deep generative models helps to bring speed & efficiency to the drug discovery process by designing virtual novel molecule having characteristics of novel drug candidates

Click here to­ read full press release/ article | Ref: Businesswire | Image: Iktos

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post